February 15, 2024 – Terumo Medical Company (TMC) not too long ago broke floor on a brand new manufacturing facility at its Caguas, Puerto Rico location. This enlargement is one other funding by Terumo as international demand for the corporate's Angio-Seal® Vascular Closure System (VCD), manufactured in Puerto Rico, continues to extend. Angio-Seal is likely one of the main vessel closure units on the worldwide market and is utilized by thousands and thousands of sufferers worldwide. It supplies lively closure for speedy and dependable hemostasis in sufferers who’ve undergone angiographic or interventional procedures. It has additionally been confirmed to speed up affected person mobility and allow same-day discharge, that means sufferers have the chance to be house for restoration shortly after their process.

The brand new 60,000 sq. meter enlargement will likely be constructed subsequent to the present location and is anticipated to be accomplished in summer time 2025. The prevailing 22,000-square-foot constructing may even be renovated to assist related manufacturing administrative necessities.

Study extra